Literature DB >> 24337913

Prevalence and clinical significance of incidental F18-FDG breast uptake: a systematic review and meta-analysis.

Francesco Bertagna1, Giorgio Treglia, Emanuela Orlando, Lodovica Dognini, Luca Giovanella, Ramin Sadeghi, Raffaele Giubbini.   

Abstract

This review aims to analyse the published data on the prevalence and clinical significance of breast incidental F18-FDG uptake detected by PET or PET/CT (BIU). A comprehensive computer literature search of the PubMed/MEDLINE, Scopus and Embase databases for studies on BIU published through July 2013 was performed. Pooled prevalence and malignancy risk of BIU were calculated. The literature search revealed 42 articles, and 17 were selected. One study was excluded because of data overlap but four additional studies were found screening the references. Finally, 20 articles were included in the systematic review and 13 were eligible for a meta-analysis. The pooled prevalence of BIU on all scans was 0.4 % (95 % CI 0.23-0.61 %), the pooled prevalence on scans on female patients only was 0.82 % (95 % CI 0.51-1.2 %), the pooled risk of malignancy of BIU when further analysed was 48 % (95 % CI 38-58 %) and the pooled risk of malignancy of BIU with histological examination was 60 % (95 % CI 53-66 %). The most frequent malignant lesion detected was infiltrating ductal carcinoma. Despite being rare, the identification of BIU frequently signals the presence of an unsuspected subclinical lesion, which differs from the indicated reason for which the patient was initially scanned, and the risk of malignancy is very high.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24337913     DOI: 10.1007/s11604-013-0270-0

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  36 in total

1.  Rapidly growing complex fibroadenoma with surrounding ductal hyperplasia mimics breast malignancy on serial F-18 FDG PET/CT imaging.

Authors:  William Makis; Anthony Ciarallo; Marc Hickeson; Vilma Derbekyan
Journal:  Clin Nucl Med       Date:  2011-07       Impact factor: 7.794

2.  Second primary malignancy of breast in a patient of gastrointestinal stromal tumor presenting as fluoro-deoxyglucose-avid breast incidentaloma in fluoro-deoxyglucose-positron emission tomography.

Authors:  Subhash K Ramani; Sandip Basu; Vani Parmar; Sumeet Gujral; Sandip Bibte
Journal:  J Cancer Res Ther       Date:  2011 Jul-Sep       Impact factor: 1.805

3.  Male primary breast cancer found on FDG-PET/CT.

Authors:  James C McEachen; Phillip H Kuo
Journal:  Clin Nucl Med       Date:  2008-09       Impact factor: 7.794

4.  Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.

Authors:  N Avril; M Menzel; J Dose; M Schelling; W Weber; F Jänicke; W Nathrath; M Schwaiger
Journal:  J Nucl Med       Date:  2001-01       Impact factor: 10.057

5.  Clinical significance of incidental finding of focal activity in the breast at 18F-FDG PET/CT.

Authors:  Bong Joo Kang; Ji Hye Lee; Ie Ryung Yoo; Sung Hun Kim; Jae Jeong Choi; Seung Hee Jeong; Hyeon Woo Yim
Journal:  AJR Am J Roentgenol       Date:  2011-08       Impact factor: 3.959

Review 6.  The role of positron emission tomographic imaging in breast cancer.

Authors:  Michelle D McDonough; Elizabeth R DePeri; Betty A Mincey
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075

7.  Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer.

Authors:  Masashi Ueno; Tetsuichiro Muto; Masatoshi Oya; Hirotoshi Ota; Kaoru Azekura; Toshiharu Yamaguchi
Journal:  Int J Clin Oncol       Date:  2003-06       Impact factor: 3.402

8.  Unexpected foci of 18F-FDG uptake in the breast detected by PET/CT: incidence and clinical significance.

Authors:  Diana Litmanovich; Konstantin Gourevich; Ora Israel; Zahava Gallimidi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-01       Impact factor: 9.236

9.  Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison.

Authors:  Harry Agress; Benjamin Z Cooper
Journal:  Radiology       Date:  2003-12-29       Impact factor: 11.105

Review 10.  The benefits and harms of breast cancer screening: an independent review.

Authors: 
Journal:  Lancet       Date:  2012-10-30       Impact factor: 79.321

View more
  13 in total

Review 1.  Present and future role of FDG-PET/CT imaging in the management of breast cancer.

Authors:  Kazuhiro Kitajima; Yasuo Miyoshi
Journal:  Jpn J Radiol       Date:  2016-01-05       Impact factor: 2.374

2.  Multicentre study of 18F-FDG-PET/CT prostate incidental uptake.

Authors:  Francesco Bertagna; Arnoldo Piccardo; Bassam Dib; Mattia Bertoli; Federica Fracassi; Giovanni Bosio; Raffaele Giubbini; Giorgio Biasiotto; Luca Giovanella; Giorgio Treglia
Journal:  Jpn J Radiol       Date:  2015-07-08       Impact factor: 2.374

3.  Prevalence and risk of malignancy of focal incidental uptake detected by fluorine-18-fluorodeoxyglucose positron emission tomography in the parotid gland: a meta-analysis.

Authors:  Giorgio Treglia; Francesco Bertagna; Ramin Sadeghi; Barbara Muoio; Luca Giovanella
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-28       Impact factor: 2.503

Review 4.  PET-CT in Clinical Adult Oncology: II. Primary Thoracic and Breast Malignancies.

Authors:  Matthew F Covington; Bhasker R Koppula; Gabriel C Fine; Ahmed Ebada Salem; Richard H Wiggins; John M Hoffman; Kathryn A Morton
Journal:  Cancers (Basel)       Date:  2022-05-29       Impact factor: 6.575

5.  Incidental Breast Lesions Identified by (18)F-FDG PET/CT: Which Clinical Variables Differentiate between Benign and Malignant Breast Lesions?

Authors:  Kyung Min Shin; Hye Jung Kim; Su Jin Jung; Hyo Soon Lim; Sang Woo Lee; Seung Hyun Cho; Yun-Jin Jang; Hui Joong Lee; Gab Chul Kim; Jin Hyang Jung; Ji Young Park
Journal:  J Breast Cancer       Date:  2015-03-27       Impact factor: 3.588

Review 6.  Application of PET Tracers in Molecular Imaging for Breast Cancer.

Authors:  Jorianne Boers; Erik F J de Vries; Andor W J M Glaudemans; Geke A P Hospers; Carolina P Schröder
Journal:  Curr Oncol Rep       Date:  2020-07-06       Impact factor: 5.075

Review 7.  Prevalence and outcomes of incidental imaging findings: umbrella review.

Authors:  Jack W O'Sullivan; Tim Muntinga; Sam Grigg; John P A Ioannidis
Journal:  BMJ       Date:  2018-06-18

8.  Clinical-Diagnostic Relevance of Breast "Incidentaloma" Detected During 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography: Correlation with Radiological Imaging and Histopathology.

Authors:  Stefano Panareo; Luca Urso; Alberto Nieri; Matteo Caracciolo; Giorgia Valpiani; Pietro Torricelli; Antonio Frassoldati; Corrado Cittanti; Marco Rollo; Mirco Bartolomei
Journal:  Indian J Nucl Med       Date:  2021-12-15

Review 9.  Prevalence of focal incidental breast uptake on FDG-PET/CT and risk of malignancy: a systematic review and meta-analysis.

Authors:  Else Marie Aarstad; Petter Nordhaug; Mohammad Naghavi-Behzad; Lisbet Brønsro Larsen; Oke Gerke; Malene Grubbe Hildebrandt
Journal:  Eur J Hybrid Imaging       Date:  2019-09-30

10.  The Frequency of Focal Thyroid Incidental Findings and Risk of Malignancy Detected by 18F-Fluorodeoxyglucose Positron Emission Tomography in an Iodine Deficient Population.

Authors:  Nina Gedberg; Jesper Karmisholt; Michael Gade; Rune V Fisker; Victor Iyer; Lars J Petersen
Journal:  Diagnostics (Basel)       Date:  2018-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.